CATimelineAuthorisation object

General timespan (max nr days)

60

Mode of approval (General)

Tacit (Silent)

ATMP/GMO trials (max nr days)

90

Mode of approval (ATMP/GMO trials)

Explicit

Mode of approval (Xenogeneic cell therapy)

Explicit approval possible before expiration of time period

This project (ECRIN Integrating Activity/ECRIN-IA) has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 284395
Feedback